Company ARPIDA Swiss Exchange

Stocks

ARPN

Biotechnology & Medical Research

Business description: ARPIDA

Sales by Activity: ARPIDA

Geographical breakdown of sales: ARPIDA

Executive Committee: ARPIDA

Composition of the Board of Directors: ARPIDA

Shareholders: ARPIDA

Holdings: ARPIDA

Company details: ARPIDA

Other Biotechnology & Medical Research

Sector

Inactive Instrument

End-of-day quote Swiss Exchange
- ^CHF	-

08-18	Evonext Holds Talks to Take Ascend Sport Public	CI
08-17	EvoNext in Advanced Negotiations with Ascend Sport Technology for Reverse Merger	MT

EvoNext Holdings Ltd, previously Evolva Holding Ltd, is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.

Fiscal Period: December	2021 (CHF)	2022 (CHF)	2023 (CHF)	2024 (CHF)	2025 (CHF)
Novel Food, Nutritional and Healthcare Ingredients	9.88M	15.54M	4.16M	-	-

See all business segments

Fiscal Period: December	2021 (CHF)	2022 (CHF)	2023 (CHF)	2024 (CHF)	2025 (CHF)
United States	4.92M	6.34M	-	-	-
Switzerland	4.96M	9.2M	-	-	-

See all geographic segments

Manager	Title	Age	Since
Doris Rudischhauser IRC	Investor Relations Contact	59	-

See ARPIDA governance

Director	Title	Age	Since
Francesco Defila BRD	Director/Board Member	-	2025-03-26
Gianluca Ferrari CHM	Chairman	-	2025-03-26

Composition of the Board of Directors

Name	Stocks	%	Valuation
Hal Fund Services Ireland Ltd. 19.32 %	1,396,957	19.32 %	4 M CHF
Pegasus Global Opportunity Fund Ltd. 9.59 %	693,417	9.59 %	2 M CHF
Alpha Capital AG 9.386 %	678,671	9.386 %	2 M CHF
North Certus SA 4.34 %	313,809	4.34 %	849 443 CHF
Nice & Green SA 3 %	216,918	3 %	587 171 CHF

List of ARPIDA shareholders

Name	Stocks	%	Valuation
EVONEXT HOLDINGS SA 0.26%	19,074	0.26%	51 631 $

Evolva Holding SA

Duggingerstrasse 23

4153, Reinach

+41 61 485 2000

http://evonextholdings.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.09%	+5.26%	+4.44%	+26.03%	51.61B
REVOLUTION MEDICINES, INC.	-1.07%	+2.82%	+474.18%	+601.24%	44.89B
IQVIA HOLDINGS INC.	+1.47%	+9.79%	+40.15%	+21.21%	42.77B
BEONE MEDICINES AG	+1.44%	+7.77%	+19.27%	+90.94%	42.58B
CELLTRION, INC.	-0.93%	-4.33%	+17.87%	+51.96%	31.82B
MEDPACE HOLDINGS, INC.	+1.32%	+7.30%	+36.93%	+152.36%	17.33B
ASCENDIS PHARMA A/S	-0.60%	+1.93%	-	-	16.63B
EUROFINS SCIENTIFIC SE	+0.03%	+3.41%	+7.12%	+35.49%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	+5.41%	+91.01%	+46.93%	14.09B
Average	+0.45%	+4.43%	+86.37%	+128.27%	30.72B
Weighted average by Cap.	+0.49%	+4.72%	+102.57%	+148.52%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research